Search Press releases Keywords From To 1 Apr 2016 Acquisition of own shares April 1, 2016 Read More 24 Mar 2016 Nominations for new members of UCB's Board of Directors Read More 23 Mar 2016 UCB Announces Results from First Head-to-Head study of Cimzia® (certolizumab pegol) and Humira® (adalimumab) in Bio-Naïve Rheumatoid Arthritis Patients Read More 21 Mar 2016 UCB and Amgen announce positive topline results from phase 3 study evaluating romosozumab in men with osteoporosis Read More 26 Feb 2016 UCB with progress on its growth path delivering value to patients and shareholders Read More 22 Feb 2016 UCB And Amgen Announce Positive Topline Results From The Phase 3 Study Of Romosozumab in Postmenopausal Women With Osteoporosis Read More Pagination First page Previous page Previous … Page 91 Page 92 Page 93 Page 94 Current page 95 Page 96 Page 97 Page 98 Page 99 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
